Exactech Highlights First Shoulder Surgeries Using Equinoxe PHx system

The system features modernized implant designs, additional calcar screw options, and innovative screw configurations.

Katie Hobbins, Managing Editor

June 18, 2024

1 Min Read
 Equinoxe PHx System
Image courtesy of Cision PR Newswire

Exactech, an orthopedic medical device company, recently announced the first surgeries using its Equinoxe PHx system after receiving FDA 510(k) clearance in September 2023.

The PHx system expands the company’s shoulder portfolio under the Equinoxe shoulder system name, which allows surgeons to seamlessly transition from primary shoulder procedures to more complex reconstructions without the need for stem removal. PHx introduces a proximal humerus locking plate system to allow accommodation to different fractures, tailoring care to patient needs. A 20-plate system, the device includes Exactech Ecac-Loc screws that feature patented Exac-Loc technology to use deployable and retractable talons designed for added fraction stabilization by “increasing the surface area of fixation into the proximal humeral bone,” according to the press release announcing the milestone.

The system — introduced to the market by Markus Scheibel, MD, of Schulthess Clinic Zurich and Charite University, at the Paris International Shoulder Course earlier this year — features modernized implant designs, additional calcar screw options, and innovative screw configurations.

"This new system provides not only a much-improved set of traditional plates for proximal humerus fixation, but also a novel ‘Victory’ plate designed around the importance of tuberosity fixation, a dedicated small-profile plate for the greater tuberosity, and talon technology designed to minimize head settling," said Joaquin Sanchez-Sotelo, MD, PhD, American Shoulder and Elbow Society (ASES) president elect, of the Division of Shoulder and Elbow Surgery at Mayo Clinic.

The company said the PHX system is scheduled to expand to limited US launch in Q3 2024, with plans to enter other markets in 2025.

"Our aim was to develop a comprehensive system that transcends current limitations, offering a myriad of options tailored to each patient's anatomy, bone quality, fracture type and lifestyle,” said Kenneth Egol, MD, of NYU Langone, in the release.

About the Author(s)

Katie Hobbins

Managing Editor, MD+DI

Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like